Log In
Register
Facebook icon
Instagram icon
Twitter X icon
LinkedIn icon
Business
Research
Treatments
News
Products
Multimedia
Site Map
2014
June
13
Allergan Board Unanimously Rejects Revised Unsolicited Proposal from Valeant
Valeant Pharmaceuticals Announces FDA Approval Of Jublia for Onychomycosis
More Than Half of Consumers Considering Cosmetic Procedures
Page 1 of 1